214 related articles for article (PubMed ID: 28821879)
1. Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.
Chen HY; Lin LT; Wang ML; Laurent B; Hsu CH; Pan CM; Jiang WR; Chen PY; Ma HI; Chen YW; Huang PI; Chiou A; Chiou SH
Sci Rep; 2017 Aug; 7(1):8710. PubMed ID: 28821879
[TBL] [Abstract][Full Text] [Related]
2. Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.
Chen HY; Lin LT; Wang ML; Lee SH; Tsai ML; Tsai CC; Liu WH; Chen TC; Yang YP; Lee YY; Chang YL; Huang PI; Chen YW; Lo WL; Chiou SH; Chen MT
Oncotarget; 2016 Jul; 7(27):42485-42501. PubMed ID: 27285760
[TBL] [Abstract][Full Text] [Related]
3. Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.
Lin JC; Tsai JT; Chao TY; Ma HI; Liu WH
Neoplasia; 2019 May; 21(5):459-468. PubMed ID: 30959276
[TBL] [Abstract][Full Text] [Related]
4. Musashi-1 promotes chemoresistant granule formation by PKR/eIF2α signalling cascade in refractory glioblastoma.
Chen HY; Lin LT; Wang ML; Tsai KL; Huang PI; Yang YP; Lee YY; Chen YW; Lo WL; Lan YT; Chiou SH; Lin CM; Ma HI; Chen MT
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1850-1861. PubMed ID: 29486283
[TBL] [Abstract][Full Text] [Related]
5. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
6. RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.
Uren PJ; Vo DT; de Araujo PR; Pötschke R; Burns SC; Bahrami-Samani E; Qiao M; de Sousa Abreu R; Nakaya HI; Correa BR; Kühnöl C; Ule J; Martindale JL; Abdelmohsen K; Gorospe M; Smith AD; Penalva LO
Mol Cell Biol; 2015 Sep; 35(17):2965-78. PubMed ID: 26100017
[TBL] [Abstract][Full Text] [Related]
7. Musashi-1 promotes stress-induced tumor progression through recruitment of AGO2.
Chen HY; Wang ML; Laurent B; Hsu CH; Chen MT; Lin LT; Shen J; Chang WC; Hsu J; Hung MC; Chen YW; Huang PI; Yang YP; Li CP; Ma HI; Chen CH; Lin WC; Chiou SH
Theranostics; 2020; 10(1):201-217. PubMed ID: 31903115
[TBL] [Abstract][Full Text] [Related]
8. The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.
Vo DT; Abdelmohsen K; Martindale JL; Qiao M; Tominaga K; Burton TL; Gelfond JA; Brenner AJ; Patel V; Trageser D; Scheffler B; Gorospe M; Penalva LO
Mol Cancer Res; 2012 Jan; 10(1):143-55. PubMed ID: 22258704
[TBL] [Abstract][Full Text] [Related]
9. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF
RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859
[TBL] [Abstract][Full Text] [Related]
10. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO
RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409
[TBL] [Abstract][Full Text] [Related]
12. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
13. IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65.
Bhargava S; Visvanathan A; Patil V; Kumar A; Kesari S; Das S; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Oncotarget; 2017 Jun; 8(25):40469-40485. PubMed ID: 28465487
[TBL] [Abstract][Full Text] [Related]
14. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
[TBL] [Abstract][Full Text] [Related]
15. Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development.
Velasco MX; Kosti A; Guardia GDA; Santos MC; Tegge A; Qiao M; Correa BRS; Hernández G; Kokovay E; Galante PAF; Penalva LOF
RNA; 2019 Jul; 25(7):768-782. PubMed ID: 31004009
[TBL] [Abstract][Full Text] [Related]
16. PUM2 Promotes Glioblastoma Cell Proliferation and Migration via Repressing BTG1 Expression.
Wang Y; Sun W; Yang J; Yang L; Li C; Liu H; Liu X; Jiao B
Cell Struct Funct; 2019; 44(1):29-39. PubMed ID: 30787206
[TBL] [Abstract][Full Text] [Related]
17. Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1.
Lan L; Appelman C; Smith AR; Yu J; Larsen S; Marquez RT; Liu H; Wu X; Gao P; Roy A; Anbanandam A; Gowthaman R; Karanicolas J; De Guzman RN; Rogers S; Aubé J; Ji M; Cohen RS; Neufeld KL; Xu L
Mol Oncol; 2015 Aug; 9(7):1406-20. PubMed ID: 25933687
[TBL] [Abstract][Full Text] [Related]
18. Musashi-1 Regulates MIF1-Mediated M2 Macrophage Polarization in Promoting Glioblastoma Progression.
Yang YP; Chien CS; Yarmishyn AA; Chan MS; Lee AC; Chen YW; Huang PI; Ma HI; Lo WL; Chien Y; Lin WC; Wang ML; Chen MT
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918794
[TBL] [Abstract][Full Text] [Related]
19. A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration.
Cao X; Kaneko T; Li JS; Liu AD; Voss C; Li SS
Nat Commun; 2015 Jul; 6():7721. PubMed ID: 26166433
[TBL] [Abstract][Full Text] [Related]
20. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
Joshi R; Qin L; Cao X; Zhong S; Voss C; Min W; Li SSC
J Biol Chem; 2020 Jan; 295(2):645-656. PubMed ID: 31806702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
